Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment
Clinical trial NCT03112213 · COMPLETED
Trial details
- NCT number
- NCT03112213
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-12
- Primary completion
- 2018-07-17
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.